Skip to main content
Clinical Trials/PACTR202107604428217
PACTR202107604428217
Not yet recruiting
Phase 3

A Prospective PreecLampsia/Eclampsia Preventative Intervention – Metformin (APPLE PIE) study

Stellenbosch University0 sites1,430 target enrollmentJuly 7, 2021

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Pregnancy and Childbirth
Sponsor
Stellenbosch University
Enrollment
1430
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 7, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • All these criteria must be met to be eligible for inclusion:
  • A)At high risk of developing preeclampsia: Pregnant women who have chronic hypertension AND/OR have had a previous pregnancy complicated by preterm preeclampsia (before 34 weeks gestation) AND/OR had preeclampsia complicating 2 or more previous pregnancies
  • B)Gestational age between 12w 0d and 26w 0d
  • C)Viable singleton pregnancy
  • D)Be able to understand the information provided, with the use of an interpreter if needed, and be able to give informed consent
  • E)Be willing to take the trial medication daily until delivery

Exclusion Criteria

  • Any of the following will be considered an exclusion criterion:
  • A)Under 18 years of age
  • B)Known fetal anomaly
  • C)Unable or not willing to give consent
  • E)Contraindication to the use of metformin
  • F)Currently using metformin
  • G)Previously enrolled in this trial. Participants will only be able to enrol for this trial once and not again in the next pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials